| Zaman aralığı | Tahmini Fiyat | Geçmiş | Tarihsel | İç yüzü |
|---|---|---|---|---|
| Yarın | $49.81 ▲ +1.41% | Dün | $48.83 ▼ -0.59% | Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.12 and targets $49.81 (+1.41%). The near-term read is upside; watch $50.59 / $47.65 because daily realized volatility is about 7.29%. |
Tomorrow's Supernus Pharmaceuticals Inc. Common Stock (SUPN) setup is anchored to $49.12 and targets $49.81 (+1.41%). The near-term read is upside; watch $50.59 / $47.65 because daily realized volatility is about 7.29%. | ||||
| Hafta | $51.28 ▲ +4.40% | Geçen hafta | $48.21 ▼ -1.85% | The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $48.21 to $51.28 (+4.40%). It gives upside momentum context for this stock, so breaks around $50.59 / $47.65 matter more than a single tick. |
The 7-day Supernus Pharmaceuticals Inc. Common Stock model moves from $48.21 to $51.28 (+4.40%). It gives upside momentum context for this stock, so breaks around $50.59 / $47.65 matter more than a single tick. | ||||
| Ay | $53.72 ▲ +9.37% | Geçen ay | $47.19 ▼ -3.94% | The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.72 (+9.37%), compared with the live reference near $49.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Supernus Pharmaceuticals Inc. Common Stock target is $53.72 (+9.37%), compared with the live reference near $49.12. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Yıl | $57.38 ▲ +16.82% | Geçen sene | $45.65 ▼ -7.07% | The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $57.38 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Supernus Pharmaceuticals Inc. Common Stock scenario points to $57.38 (+16.82%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Yıl | $65.96 ▲ +34.29% | 5 Yıl Önce | $42.05 ▼ -14.40% | The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $65.96 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Supernus Pharmaceuticals Inc. Common Stock view is $65.96 (+34.29%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Gösterge | Değer | Sinyal |
|---|---|---|
| Price | $49.12 | Mid |
| Daily Change | -4.16% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 66% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $49.12 | Daily Change | -4.16% |
| Market Cap | $2.82B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.